[Determination of glufosinate and its metabolite residues in tea by ultra-high performance liquid chromatography-tandem mass spectrometry coupled with precolumn derivatization]. [PDF]
Bi RF +5 more
europepmc +1 more source
[Research progress on clinical transformation of Piezo1 in osteoarthritis]. [PDF]
Wang Y, Wei N, Zheng Z.
europepmc +1 more source
[Burden and epidemiological trends of alcohol use disorder and alcoholic liver disease in the Asia-Pacific region]. [PDF]
Zhuang QC, Yang CQ.
europepmc +1 more source
[Interpretation of the Expert Consensus Statement on the Role of Vitamin D in Metabolic Health]. [PDF]
Zhao Z, Zeng Y.
europepmc +1 more source
[Considerations on clinical trial issues related to new drug development for metabolic and alcohol-associated liver disease and fatty liver disease]. [PDF]
Wang XY, Sun HM, Gao YH.
europepmc +1 more source
[<b>"</b>Triple-hit<b>"</b> pathogenic mechanism of Leber hereditary optic neuropathy]. [PDF]
Wang K, Li S, Zhang Y, Guan M.
europepmc +1 more source
[Occurrence status and treatment strategies of abnormal growth and development in children with methylmalonic acidemia]. [PDF]
Wei HY, Li DX.
europepmc +1 more source
[Simultaneous determination of five common pyrethroid metabolites in urine using liquid-liquid extraction coupled with ultra performance liquid chromatography-tandem mass spectrometry]. [PDF]
Zhang XM, Meng XJ, Hu Y, Liu XD.
europepmc +1 more source
[Interpretation of key updates of the 2026 version of the APASL clinical practice guidelines for the management of chronic hepatitis B]. [PDF]
Liu HS, Ai XW, Sun YM, You H.
europepmc +1 more source
[Lactate induces gastric mucosal injury by promoting M1 polarization of macrophages <i>via</i> the cardio-gastric axis]. [PDF]
Yang Y, Jia Y, Yin G, Li S, Yang P.
europepmc +1 more source

